Thomas S Gifford insider trades: Scivanta Medical (SCVM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 5, 2007 | SCVM | ↑ Buy | 625,000 | $0.20 | $125K | Direct | Feb 8, 2007 (3d) |
| Aug 25, 2005 | MHUT | ↑ Buy | 500,000 | $0.05 | $25K | Direct | Aug 29, 2005 (4d) |
| May 14, 2004 | MHUT | ↑ Buy | 937,500 | $0.08 | $75K | Direct | Sep 29, 2005 (503d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas S Gifford's insider trades
Thomas S Gifford is Exec. VP, CFO and Secretary at Scivanta Medical (SCVM). Since May 14, 2004, Thomas has reported 3 open-market purchases worth $225K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), other transactions (6 filings), option exercises (3 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCVM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.